Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. Februar 2023 07:05 ET | Quelle: uniQure Inc.

uniQure announces the European Commission approval of the first gene therapy for adults with hemophilia B

~ Historic approval represents the first gene therapy in Europe to treat hemophilia B and provides a new treatment option for patients that reduces the rate of annual bleeds, reduces or eliminates the...
21. Februar 2023 07:05 ET | Quelle: Clearside Biomedical, Inc.

Clearside Biomedical Announces Positive Data Presentations on CLS-AX OASIS Clinical Trial and Use of SCS Microinjector® Presented at the Angiogenesis and Macula Society Annual Meetings

- CLS-AX OASIS Results Show Favorable Safety Data, Durability and Biologic Effect Over 6 Months in Treatment-Experienced Anti-VEGF Sub-Responders - - SCS Microinjector® Featured in Favorable Data...
21. Februar 2023 07:04 ET | Quelle: Gilat Satellite Networks Ltd.

Gilat Enables TIM Brasil to Be First Network Operator with Coverage to 100% of Brazilian Cities

PETAH TIKVA, Israel, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...
21. Februar 2023 07:01 ET | Quelle: Draganfly Inc

Draganfly to Showcase its Drone and AI Technology at the World Police Summit in Dubai

The Draganfly team will be located at booth #8A29 to demonstrate how the company’s new Heavy Lift, Commander 3XL Drone, and Vital Intelligence Technology are used to enhance public safety. Dubai,...
21. Februar 2023 07:00 ET | Quelle: IN8bio, Inc

IN8bio to Present at the H.C. Wainwright Cell Therapy Virtual Conference

NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company discovering and developing innovative gamma-delta T cell therapies, today...
21. Februar 2023 07:00 ET | Quelle: Evoke Pharma, Inc.

Evoke Pharma and EVERSANA Selected to Present Results of Real-World Healthcare Utilization Study Comparing GIMOTI® and Oral Metoclopramide at the Digestive Disease Week Plenary Session

SOLANA BEACH, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
21. Februar 2023 07:00 ET | Quelle: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Key Milestones

—ORLADEYO net revenue of $70.7 million for Q4 2022 and $251.6 million for FY 2022— —ORLADEYO net revenue in 2023 expected to be no less than $320 million— —ORLADEYO peak sales expected to be $1...
21. Februar 2023 07:00 ET | Quelle: Olink Proteomics AB

Olink reports fourth quarter and full year 2022 financial results

UPPSALA, Sweden, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the fourth quarter and full year ended December...
21. Februar 2023 07:00 ET | Quelle: Regeneron Pharmaceuticals, Inc.

Pozelimab (C5 Antibody) BLA for Treatment of Children and Adults with Ultra-rare CHAPLE Disease Accepted for FDA Priority Review

If approved, pozelimab would be the first and only treatment for those living with CHAPLE CHAPLE is an ultra-rare hereditary immune disease that causes overactivation of the complement system,...
21. Februar 2023 07:00 ET | Quelle: Century Therapeutics, Inc.

Century Therapeutics to Present at Upcoming Investor Conferences

PHILADELPHIA, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative clinical-stage biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell...

Vorherige Seite

Nächste Seite